Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Sarcopenia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Motor Activity 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Liver Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Sorafenib 68Bevacizumab 44Oxaliplatin 25Doxorubicin 22Gemcitabine 21Fluorouracil 21Radiosurgery 20Nivolumab 19durvalumab 18Radiofrequency Ablation 18pembrolizumab 17lenvatinib 17Cisplatin 17Capecitabine 17atezolizumab 14Leucovorin 14Hepatectomy 14Radiotherapy 12tremelimumab 10Irinotecan 10Drug Therapy 10Cyclophosphamide 10Carboplatin 10Blood Specimen Collection 10Ipilimumab 9regorafenib 8Liver Transplantation 8Everolimus 8Cryosurgery 8Chemotherapy, Adjuvant 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × Hand Strength × Clear all
NCT05443230 2023-09-13

Effect of Sarcopenia on HCC After Lenvatinib and Anti-PD-1 Treatment

First Affiliated Hospital of Wenzhou Medical University

Unknown
200 enrolled
Gastrointestinal

Liver Neoplasms, Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡